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Clostridium scindens VPI 12708 (previously known as Eubacterium sp. VPI 12708) is a 
bile-acid dehydroxylating bacterium originally isolated from the feces of a colon cancer 
patient. Many genes required for bile acid 7-α dehydroxylation are found on a large bile 
acid inducible operon (bai) that has been extensively studied. However the bai promoter, 
which directs expression of the bai operon, has yet to be characterized due, in part, to a 
lack of a functional genetic transfer system for this strain. A spontaneous rifampin-
resistant Clostridium scindens VPI 12708 mutant was used as a recipient to determine the 
efficacy of conjugation as a method of DNA transfer. The Clostridium perfringens 
plasmid pECU-001, containing a chloramphenicol acetyl transferase marker, and the 
Birmingham IncP-α oriT was transformed into Escherichia coli S17-1 which was used as 
a donor for conjugation. E. coli EM24 (Rif R) served as a recipient to ensure the donor 
was conjugal. All bacterial cultures were grown to mid-log phase and harvested by 
centrifugation. Matings between the donor and recipient were carried out on the surface 
of anaerobic tryptic soy agar slants. Chloramphenicol-resistant E. coli EM24 colonies 
were isolated suggesting E. coli S17-1 was conjugal under the conditions tested. 
Chloramphenicol-resistant Clostridium scindens VPI 12708 (RifR) colonies were isolated 
using both 4:1 and 1:4 (vol:vol) donor: recipient ratios. Plasmid preparations with 
 viii
subsequent restriction map analysis from putative Clostridium scindens VPI 12708 
transconjugants confirmed the presence of pECU-001. Conjugal transfer of pWKU-001 
(which is pECU-001 with the bai promoter insert and a downstream β-glucuronidase 
reporter gene) was attempted using a similar protocol, but with erythromycin as selection 
for recipient. The plasmid was successfully introduced into C. scindens, however pWKU-
001 was not maintained and lost from the culture. These data suggest DNA can be 
introduced into Clostridium scindens VPI 12708 via E. coli S17-1-mediated conjugal 
transfer, which may prove useful for the study of the genetic regulation of the bai 
promoter. Unfortunately, pWKU-001 appears to be unstable and unsuitable in present 
form for extensive studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1
 CHAPTER I 
 
INTRODUCTION 
 
 
Cholesterol is either synthesized de novo in the liver of animals or obtained from dietary 
sources. Dietary cholesterol is absorbed from the small intestine and is transported to and 
metabolized in the liver to form primary bile acids. The conversion of cholesterol, independent 
of source, to primary bile acids is one of the two major means of excretion of cholesterol from 
the body (40%), the other being canalicular secretion of cholesterol into the bile (60%) (49). Bile 
acid biosynthesis converts water insoluble cholesterol to water-soluble metabolites that can be 
readily excreted in the bile and feces (10, 11, 12, 50). The primary bile acids formed in the liver 
of humans are cholic acid (3α, 7α, 12α-trihydoxy-5β-cholanic acid) and chenodeoxycholic acid 
(3α, 7α-dehydoxy-5β-cholanic acid) (Fig.1). More than 99% of these metabolites are 
conjugated, predominantly with glycine and taurine residues attached to the side-chain carboxyl 
group via an amide linkage, resulting in a C24 structure (51).  
 
Primary bile acids are secreted into the canalicular bile in the liver, and enter the gall bladder 
via the hepatic duct, where they are stored temporarily. Food in the stomach and duodenum 
signals the release of cholecystokinin, which causes the contraction of the gall bladder and 
release of bile into the duodenum. Bile acids constitute the predominant solute in bile and reach 
concentrations of ~20-30 mM (12 g/L) (50).  
 
     Primary bile acids are amphiphilic molecules, forming micelles in an aqueous solution. An 
exterior hydrophilic face and interior hydrophobic ends are responsible for the amphiphilic 
nature of the primary bile acids (50), which ensures that biliary cholesterol remains in solution. 
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Upon secretion into the lumen, bile acids act as organic detergents and play an important role in 
the intraluminal solubilization, absorption and transport of biliary lipids such as cholesterol and 
lecithin, dietary lipids such as monoglycerides and free fatty acids, cholesterol and other sterols, 
and fat-soluble vitamins.  
 
Bile acids are actively reabsorbed in the terminal ileum and returned to the liver via the portal 
vein. The presence of high-affinity receptors in the terminal ileum enables efficient reabsorption 
and is due to a sodium-bile co-transporter. Approximately 95% of the circulating bile acids are 
absorbed from the ileum and returned to the liver. The cycling of bile acids from the liver to the 
gall bladder, duodenum, intestine, and back to the liver via the portal blood is known as the 
enterohepatic circulation. Bile acids circulate about two times with each meal or approximately 
eight to ten times a day, depending on the individual (7).  
 
Approximately 0.2-0.65 grams per day (5% of the bile acid pool) of bile acids are not 
reabsorbed in the terminal ileum and therefore enter the large intestine (50). The bile acids that 
enter the large intestine undergo extensive modification by the intestinal microflora. The 
microflora of the human colon consists of predominantly anaerobic bacteria, largely belonging to 
the genera Bacteroides, Eubacterium and Clostridium (35). In humans, at least fifteen to twenty 
metabolites are generated from the primary bile acids cholic acid and deoxycholic acid by 
intestinal biotransformation (23, 50). The known biotransformations include deconjugation of the 
glycine and taurine residues on the primary bile acids by bile salt hydrolase, yielding free bile 
acids. Free bile acids undergo subsequent dehydroxylation at the 7α position, and/or conversion 
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of hydroxy to ketone groups at the 3, 7 and 12 positions and reduction back to the hydroxy form 
by stereospecific bile acid hydroxysteroid dehydrogenases (oxidoreductases) (19, 24).  
 
Quantitatively, the most important biotransformation is that of the irreversible 7α-
dehydroxylation of cholic acid and chenodeoxycholic acid, resulting in the formation of the 
secondary bile acids deoxycholic acid (3α, 12α-dihydoxy-5β-cholanic acid) and lithocholic acid 
(3α hydoxy-5β-cholanic acid), respectively (19, 44) (Fig. 1). The biotransfomations in the colon 
are limited due to the constraints imposed by the highly anaerobic environment, with reductive 
reactions being strongly favored over oxidative reactions (39). Even though intestinal bacteria 
can oxidize bile acids under certain conditions, almost all the bile acids isolated from the feces 
are in a reduced form (8).  Hence, it would follow that the reductive reaction of 7α-
dehydroxylation of primary bile acids is quantitatively an important biotransformation occurring 
the human intestinal tract (46).  
 
7α-dehydroxylation of cholic acid and chenodeoxycholic acid alters the physical character 
and physiological function of the steroid. Removal of the hydoxyl group increases the 
hydrophobicity and alters the critical micellar concentation, decreasing its solubility in aqueous 
solutions and rendering it more toxic to the host cells (50). Lithocholic acid is the most 
hydrophobic of all the bile acids, and hence, only a small fraction is reabsorbed by passive non-
ionic transport from the colon into the bloodstream. The small fraction that is reabsorbed is 
transported back to the liver, and is converted to sulfolithocholate by addition of sulfate groups 
to the hydroxyl moieties. Sulfolithocholate is highly water-soluble and is lost rapidly in the feces 
and/or urine, and contributes little to the circulating bile acid pool in humans (50). Much of the 
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deoxycholic acid formed in the colon, on the other hand, can be passively reabsorbed by non-
ionic diffusion (22, 50, 54), and enters the bile acid pool. In humans, deoxycholic acid cannot be 
7α-hydroxylated in the liver, and the percentage of deoxycholic acid in the bile acid pool varies 
greatly, anywhere between zero to forty percent (5, 50). Deoxycholic acid and lithocholic acid 
together constitute about twenty to twenty-five percent of the bile acid pool (44). The four bile 
acids, cholic acid, chenodeoxycholic acid, deoxycholic acid and lithocholic acid, together 
contribute greater than 99% of the bile acid pool (45). Fecal loss of bile acids is about 400-
600mg/day and compensated by de novo bile acids biosynthesis (50). 
 
The amount of deoxycholic acid in the bile acid pool is related to colonic transit time (32), 
colonic pH (48), solubilization and absorption of bile acids from the colon (48), and the levels 
and relative activities of 7α-dehydroxylating bacteria in the intestine (5, 53). Increased levels of 
deoxycholic acid in the serum and bile have been observed with increased levels and higher 
activities of 7α-dehydroxylating bacteria in the colon.   
 
Increased levels of deoxycholic acid in bile, serum and feces have been associated with an 
increased likelihood of cholesterol gallstone disease (26, 32) and colon cancer (33, 36). The level 
of deoxycholic acid in the bile acid pool correlates with the cholesterol saturation index of the 
bile (42). Cholesterol gallstone patients, with a high percentage of deoxycholic acid level in bile, 
have approximately a 1000-fold increase in the level of 7α-dehydroxylating bacteria in their 
intestines compared to patients with lower deoxycholic acid levels (5, 53). This implies that 
levels of 7α-dehydroxylating bacteria control the cholesterol saturation index of bile, an 
important factor in the pathogenesis of gallstones (5).  
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Only a few strains of Clostridium and Eubacterium are known to have 7α-dehydroxylating 
ability (6, 14, 16, 18, 20, 21, 34, 46, 47). The incidence of these 7α-dehydroxylating organisms 
is low, with a fecal concentration of 7α-dehydroxylating bacteria ranging from 102 to 105 viable 
organisms per gram wet feces (21, 46, 47). Members of the genera Clostridium and Eubacterium 
are obligately anaerobic Gram-positive rods, with some being non-sporogenic (47). The 
morphologies of the members in these two genera tend to be similar, and the bacteria are usually 
irregular rods, with viscous growth and production of gas in rich broth, and colonies on agar 
plates of <2mm, circular, low convex and translucent or semiopaque morphology (47). 
 
Bacterial bile acid 7α-dehydroxylation is a complex process, but recent studies have 
elucidated much of the pathway in Clostridium scindens VPI 12708. This bacterium was 
previously identified as Eubacterium sp. VPI 12708, but has since been grouped into the genus 
Clostridium after 16s rRNA sequencing and DNA-DNA similarity experiments (25). Cholic acid 
7α-dehydroxylation is a multi-step pathway requiring at least eight separate enzymes (4) (Fig. 2). 
The current accepted mechanism of 7α-dehydroxylation (9) involves initial transport of the 
primary bile acid into the cell by means of a 477 amino acid transporter protein (29), and 
conjugation of the primary bile acid to Coenzyme A by the enzyme CoA ligase upon entering the 
cell (28). The bile acid-CoA conjugate then undergoes sequential oxidization by the constitutive 
NADP-linked 7α-hydroxysteroid dehydrogenase enzyme in two steps, yielding the metabolites 
3-oxo (30) and 3-oxo-∆4 bile acid intermediates. Following this, the 7α hydroxyl group is 
removed by a 7α dehydratase, and the 7-dehydroxylated intermediate, 3-oxo-12-hydroxy-4,6-
cholenic acid, undergoes three sequential reductions, ultimately resulting in the secondary bile 
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acid, which is excreted from the cell (9)  (Fig. 2). The precise role of 7α-dehydroxylation in the 
cell physiology is unclear. However, it has been proposed that by this process, the 7α-
dehydroxylating bacterium is provided with an ancillary electron acceptor (23). It has been 
demonstrated that the reductive steps of bile acid 7α-dehydroxylation in cell extracts are 
stimulated by addition of free flavins, suggesting that a flavin-linked reaction may be required 
for 7α-dehydroxylation (52), with the enzyme NADH: flavin oxidoreductase possibly supplying 
the free flavin required for 7α-dehydroxylation (55). 
 
Studies done on the mechanism of  7α-dehydroxylation in the fecal isolate Clostridium 
scindens VPI 12708 have shown that the activity is induced by cholic acid (55). Most of the 
enzymes needed for the bile acid 7α-dehydroxylation of primary bile acids are encoded by genes 
on a large (~12kb) operon, called the bai or bile acid inducible operon, which has been cloned 
and sequenced (31, 56) (Fig. 3). The bai operon  encodes nine open reading frames (baiA to 
baiI), and the functions of most of the proteins encoded have been determined. The baiB gene is 
the first open reading frame in the bile acid-inducible operon and encodes a bile acid-CoA ligase, 
which catalyses the initial step in the pathway of 7α-dehydroxylation (28). Several known 7α-
dehydroxylating bacteria possess the bai operon (14). Following induction of cholic acid, whole 
cell assays reveal two distinct groups, one exhibiting relatively high and the other low activity of 
7α-dehydroxylation. The fecal isolate Clostridium scindens VPI 12708 exhibits high 7α-
dehydroxylating ability.  
 
Even though much work has been done on elucidating the genes responsible for 7α-
dehydroxylation, little is known about the upstream promoter region (baiP) and the mechanism 
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of cholic acid induction. Also, the precise location of the cholic acid responsive element and the 
mechanism of cholic acid induction is yet to be determined. Vector pWKU-001 containing the 
195bp baiP region upstream of the first open reading frame of the bai operon and the reporter 
gene uidA encoding the enzyme β-glucuronidase have been constructed using the E. coli pECU-
001 (Doerner, K.C., unpublished data, 1999) (Fig. 4). pWKU-002 (Fig. 6) was derived from 
pWKU-001 by addition of a transcriptional terminator downstream of the uidA gene. pECU-001 
is a derivative of the Clostridium perfringens shuttle vector pJIR750 (3) and has the RP4 oriT 
inserted at the SpeI site (James Coleman, personal communication). 
 
In order to potentially identify the regulatory elements that influence the transcriptional 
activity of the bile acid inducible promoter in Clostridium scindens VPI 12708, a method is 
required to efficiently and stably transfer genetic material into the cell. Even though it is 
relatively routine to transfer genetic material into Gram-negative species such as Escherichia 
coli, it is much more difficult to do so in Gram-positives, and more so in anaerobes.  Here, we 
have attempted to develop conjugation as a method of stable gene transfer in our laboratory.  
 
Little work has been done in developing a genetic system in Gram-positive bacteria and 
anaerobes, as there are many problems to be considered. Gram-positive bacteria have thick 
peptidoglycan cell walls that have to be penetrated to transfer DNA. It is also more difficult to 
transfer DNA under anaerobic conditions using traditional bench top techniques. Usually an 
anaerobic chamber is used for this purpose, however this makes the process more tedious and 
cumbersome. The DNA that is transferred should be stable and the encoded genes should be 
expressed in the recipient. In order to do so, there must be an efficient transfer and replication 
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machinery in the recipient that can act on the vector effectively. Also, there should be an 
effective method of selecting for the recipients that have received the genetic material. Antibiotic 
selection markers have largely been used for this purpose. 
 
Previous studies using Clostridium perfringens and Clostridium acetobutylicum indicate that 
DNA can be transferred using electroporation-mediated transformation (1, 41). This procedure is 
relatively efficient, requires an anaerobic chamber, and produces transformants in only a few 
strains of Clostridium perfringens (41). Interestingly, using this method, DNA that is to be 
transformed must be methylated in an Escherichia coli host prior to transformation to avoid 
plasmid degradation in Clostridium acetobutylicum (37).  
 
Conjugation has been considered to be a good method of introducing DNA into an organism 
that does not have a genetic transfer system in place because of the many variables (40). To 
attempt conjugation as a means of DNA transfer into Clostridium scindens VPI 12708, there is a 
need for a stable and efficient vector. Studies have been done on the use of RP4-oriT shuttle 
vectors for conjugal transfer between E. coli S17-1, which has a chromosomally integrated RP4 
element (43), and Clostridium perfringens or Clostridium acetobutylicum (27, 57). It has been 
demonstrated that the RP4 encoded pilus and conjugation machinery can be used effectively to 
transfer genetic material from E. coli to C. perfringens (27). Here, it is predicted that this element 
will function in other Clostridium strains, specifically Clostridium scindens VPI 12708Rif. 
Clostridium perfringens pECU-001 uses an RP4 mechanism for transfer and is employed as the 
shuttle / cloning vector and Escherichia coli S17-1 is used as the conjugal donor. Rifampin and 
chloramphenicol are used for selection of transconjugants. Furthermore, a bench top method of 
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DNA transfer is attempted here in an effort to simplify the process, without necessitating the 
need for an anaerobic chamber.                          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 10
 
 
 
 
 
 
FIG. 1.    Chemical structure of primary and secondary bile acids. The primary bile acids cholic 
acid (3α, 7α, 12α-trihydoxy-5β-cholanic acid) and chenodeoxycholic acid (3α, 7α-dehydoxy-
5β-cholanic acid) are converted by the process of 7α-dehydroxylation into the secondary bile 
acids deoxycholic acid (3α, 12α-dihydoxy-5β-cholanic acid) and lithocholic acid (3α hydoxy-
5β-cholanic acid) respectively. 
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FIG. 2. Proposed pathway for the 7a-dehydroxylation of cholic acid in Clostridium scindens VPI 
12708 (13, 58). Bile acid intermediates include: (A). 7α, 12α-dihydoxy-5β- cholyl-CoA. (B). 
7α, 12α-dihydoxy-3-oxo-4-cholenyl-CoA. (C).  7α, 12α-dihydoxy-3-oxo-4-cholenoic acid. (D). 
12α-hydoxy-3-oxo-4,6-choldienoic acid. (E.). 12α-hydoxy-3-oxo-4-cholenoic acid. (F). 12α-
dihydoxy-3-oxo-5β-cholanic acid. (G). 3α, 12α- dihydoxy-5β-cholanic acid. 
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FIG. 3. Bile acid inducible (bai) operon from Clostridium scindens VPI 12708. P, upstream 
promoter (baiP). The alphabets B, C, D, E, A2, F, G, H and I indicate the various open reading 
frames of the bai operon. The function of various bai gene products are indicated. Abbr: Unk, 
unknown; 3α-HSDH, 3α-hydroxysteroid dehydrogenase; trasnporter, bile acid transporter; 
NADH-FOR, NADH: flavin oxidoreductase (31). 
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CHAPTER II 
MATERIALS AND METHODS 
 
Bacterial strains 
Escherichia coli S17-1, a Gram negative facultative anaerobe with a Birmingham IncP RP4 
plasmid integrated into the chromosome (43), was used as the donor bacterium in all conjugation 
experiments. E. coli S17-1 is an excellent donor of plasmids harboring the RP4 oriT as the 
chromosomally integrated RP4 molecule can mobilize appropriate nonconjugative and 
mobilizable plasmids as effectively as autonomous Birmingham IncP plasmids, with a broad-
host range, with the advantage that the RP4 plasmid cannot be transferred to the recipient cells 
(27, 43). pECU-001, pWKU-001 and pWKU-002 all harbor the RP4-oriT and were transformed 
into competent E.coli S17-1 cells by the standard CaCl2 method of transformation (2), with 
selection for chloramphenicol resistance. Clostridium scindens VPI 12708 is an encapsulated 
Gram positive obligate anaerobe isolated from the feces of a colon cancer patient by Dr. 
Hammann and characterized by Dr. Holedeman and Dr. Moore at the Anaerobe laboratory, 
Virginia Polytechnic Institute (55). A spontaneous rifampin resistant mutant isolated by Dr. K.C. 
Doerner (unpublished data, 1999) was used for the purposes of this study. E. coli EM24NR 
exhibiting rifampin resistance was used as a conjugal control (recipient) in this study.  
 
Culture media 
     All Escherichia coli strains were cultured aerobically by shaking at 210 rpm at 37ºC in Luria-
Bertani (LB) medium (10 g of tryptone (Fisher Scientific, Fairlawn, NJ), 5 g of NaCl (Fisher 
Scientific, Fairlawn, NJ), 5 g of yeast extract (Becton, Dickinson and Co., Sparks, MD), 1 liter of 
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distilled water; autoclaved, stored at 4ºC), with addition of chloramphenicol at appropriate 
concentrations. Clostridium scindens VPI 12708 was grown anaerobically in brain heart infusion 
(BHI) broth (40 ml VPI salt solution, 1 ml hemin [0.2 g hemin chloride (ICN Biomedicals, 
Aurora, Ohio), 10 ml 1N NaOH, 90 ml ddH20; autoclaved, stored at 4ºC], 4ml resazurin [25 mg 
resazurin, 100 ml ddH20], 37 g BHI (Becton, Dickinson and Co., Sparks, MD), 10 g yeast 
extract, 2 g fructose, 2.69 g sodium bicarbonate, 1 L q.s ddH2O; contents were dissolved and 
transferred to a slightly tipped round-bottom flask secured to a metal stand, boiled with nitrogen 
gas bubbling through the medium until the medium turned clear. Reduced broth was then 
transferred to clean serum top tubes flushed with nitrogen, sealed with the serum stoppers and 
clamped with aluminium seals, autoclaved and stored at room temperature (RT). Clostridium 
scindens VPI 12708Rif was plated on tryptic soy agar (TSA) plates (40 g tryptic soy agar (Becton, 
Dickinson and Co. Sparks, MD), 1 g glucose, 10 g yeast extract, 80 ml VPI salt solution, 2 g 
dibasic Na2HPO4 (ACROS Organics, NJ), 1 g L-cysteine HCl (Sigma-Aldrich Chemicals, St. 
Louis, MO), 10 ml hemin, 910 ml ddH20; mixed and pH (Beckman φTM 350 series pHmeter, 
Fullerton, CA) adjusted to 7.1 using solid sodium bicarbonate. The solution was autoclaved in an 
Erlenmeyer flask, cooled to 55ºC, antibiotics added as appropriate, and poured onto sterile 
culture plates). TSA plates were maintained anaerobically in Gas Pac Jars using anaerobic Gas 
Pac Plus catalyst (BBL Gas Pac system, Becton, Dickinson and Co., Sparks, MD). VPI salt 
solution was prepared by dissolving (per liter) 0.26 g CaCl2·2H20 and 0.48 g MgSO4·7H20 in 
800 ml ddH20 first, and then adding 1 g K2HPO4, 1 g KH2PO4, 10 g NaHCO3, 2 g NaCl; stored 
at 4ºC. All cultures were incubated at 37ºC.   
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Mating mixtures were plated on TSA plates with appropriate antibiotics added for selection 
and incubated anaerobically in Gas Pac jars. Colonies were picked and transferred to 10 ml BHI 
broth with antibiotics added for selection. Frozen stock cultures of Clostridium scindens VPI 
12708Rif and the putative transconjugants were maintained in 30% v/v glycerol and stored at –
80ºC. 
 
Antibiotic concentration 
Chloramphenicol (Sigma Chemical Co., St.Louis, MO) was prepared as a stock solution of 
34 mg/ml in 100% ethanol, with a working concentration of 20 µg/ml media. Rifampin (Sigma 
Chemical Co., St. Louis, MO) was prepared as a stock solution of 2 mg/ml in 50% ethanol and 
heated at 50ºC until dissolved (~2 hrs), with a working concentration of 20 µg/ml media. 
Erythromycin (Sigma Chemical Co., St. Louis, MO) was prepared as a stock solution of 10 
mg/ml in 100% ethanol, with a working concentration of 100 µg/ml media. All stock solutions 
were stored at 4ºC.   
 
Plasmids 
pECU-001 is a derivative of the recombinant 6568bp Clostridium perfringens plasmid 
pJIR750 (3). pJIR750 (GenBank #: L02937) was modified by the addition of the 778bp HaeIII 
fragment containing the oriT from the incompatibility group P (IncP) RK231 plasmid (GenBank 
#: L27758), inserted into the SpeI site by James Coleman (personal communication). The 7346-
bp shuttle vector pECU-001 contains a chloramphenicol acetyl transferase marker (catP gene) 
derived from Clostridium perfringens, origins of replication for E. coli (oriEC, derived from 
pUC18) and Clostridium perfringens (oriCP, derived from pIP404), a replication gene (rep) 
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derived from pIP404, lacZ’ gene from pUC18 encoding β-galactosidase, the oriT from RK231 
and a multiple cloning site (MCS) with multiple sites for restriction endonuclease digests (Fig. 
4). 
 
The 9353-bp pWKU-001 was created by Dr. K.C. Doerner and is pECU-001 with the 195-bp 
baiP fragment (bile acid inducible promoter from Clostridium scindens VPI 12708) cloned 
upstream of the reporter 1.9-kb uidA gene fragment encoding E.  coli β-glucuronidase GUS 
enzyme (15) (Fig. 5). The upstream sequence of the bai operon was kindly supplied by D. 
Mallonee and P.B. Hylemon (personal communication). pWKU-002 (9443-bp) is a derivative of 
pECU-001 with the 90-bp bile acid 7α-hydroxysteroid dehydrogenase transcriptional terminator 
(Tr) immediately downstream of the uidA gene (Fig. 6). 
 
DNA analysis 
 Plasmid DNA was extracted from E. coli and Clostridium scindens VPI 12708Rif by the 
alkaline lysis procedure using the Ultraclean Standard Mini Plasmid Prep Kit (Mo Bio 
Laboratories, Inc., Solana Beach, CA). Plasmid preparations were subjected to restriction 
enzyme digests using EcoRI, EcoRV, BamHI, HindIII, SmaI enzymes and buffers as appropriate 
(New England Biolabs, Beverly, MA and Promega, Madison, WI). Approximately 1 µg DNA 
was digested with 1 µl restriction enzyme (RE) and 1 µl of appropriate 10 X RE buffer (10 µl 
total volume) (Promega, Madison, WI) in PTC-200 Peltier thermocycler (MJ Research, 
Watertown, MA) for 6 hours at 37ºC. Samples were diluted with 3 µl 5X loading buffer 
(Promega, Madison, WI) and loaded into wells in a 1% agarose gel (Fisher Scientific, Fairlawn, 
NJ) prepared using 100 ml 1X TAE (2mM EDTA, pH 8.0; prepared as 50 X stock (242 g Tris 
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base; (Fisher Scientific, Fairlawn, NJ), 57.1 ml glacial acetic acid, 37.1 g Na2EDTA·2H2O, q.s to 
1 liter), stored at RT. One kb DNA ladder (New England Biolabs, Beverly, MA) was used as the 
molecular weight standard. The gel was subjected to electrophoresis in an electrophoresis 
chamber (BioRad Laboratories, Hercules, CA) at 15 V/cm of gel for ~30 minutes, and stained 
with 0.5-1 µg/ml ethidium bromide in solution for 30 mins, destained for 10 mins in water, and 
observed under UV light. The gel was observed using the Kodak EDAS Transilluminator (FBTI-
614, Fisher Scientific, Pittsburg, PA) and photodocumentation was performed with the Kodak 
Scientific Imaging System (New Haven, CT). 
 
Conjugation experiments 
All procedures were performed on the bench top unless otherwise indicated. All E. coli 
cultures were grown aerobically (shaking at 210 rpm) in 5 ml LB broth with respective 
antibiotics added in 10 ml Falcon tubes overnight at 37ºC. Strains were subcultured into 50 ml 
LB media in 250 ml Erlenmeyer flasks with appropriate antibiotics, and incubated with shaking 
(210 rpm) at 37ºC. Optical density (OD) at 600 nm was measured using an Ultraspec 3000 
UV/visible spectrophotometer (Pharmacia Biotech, Cambridge, England) every 30 min. When 
the OD 600nm was 0.4 to 0.6, the cultures were chilled on ice. The cultures were aseptically 
transferred to 30 ml centrifuge tubes and were pelleted by centrifugation at 9000 x g in a Sorvall 
centrifuge (RC2-B, Newtown, CT) for 5 mins, washed three times with anaerobic diluent (2 g 
gelatin, 4 ml resazurin, 5 g cysteine, 1 L VPI salt solution; boiled and flushed with nitrogen gas 
until solution became clear; transferred to serum top bottles, flushed with nitrogen gas and sealed 
with aluminium clamps; stored at RT), and resuspended in 7 ml anaerobic diluent.  
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Clostridium scindens VPI 12708 was grown for 16-20 hrs anaerobically in 100 ml BHI broth. 
The culture was aseptically and quickly transferred into four 30 ml centrifuge tubes and 
centrifuged at 9000 x g for 20 mins. The cell pellets were resuspended in 2 x 5 ml anaerobic 
diluent.  
 
The donor (E. coli S17-1 harboring the shuttle vector) and recipient (Clostridium scindens 
VPI 12708 and E. coli EM24NR (control)) cells were mixed on the surface of tryptic soy agar 
slants (5 ml TSA medium poured into screw cap 10 ml glass tubes; autoclaved; and incubated 
RT on a slant) in various volume:volume (v/v) ratios. The agar slants were spun in a clinical 
centrifuge (9000 rpm, 10 mins) to immobilize the cells on the surface of the medium. The 
supernatant was removed using a 1ml syringe and 18-gauge needle, and the slant cultures were 
incubated upside down at 37ºC for 24 hrs (40). The cells were harvested aseptically by 
resuspension in 200 µl of anaerobic diluent and rapid vortexing. The cell suspensions were 
plated onto selective TSA plates (with antibiotics added for selection) and incubated 
anaerobically in a Gas Pac jar for 36-48 hrs. The putative transconjugant colonies were picked 
and restreaked for isolation. The colonies were inoculated into BHI broth with antibiotics and 
maintained in broth by serial transfer. Gram staining and gel electrophoretic analysis of the 
plasmid preparations were performed to confirm the transconjugants. Transconjugants were 
stored by freezing by addition of two volumes of sterile glycerol in 5 ml screw cap tubes and 
held at  –70ºC. 
 
For control purposes, donor and recipient cell suspensions obtained after centrifugation (prior 
to mating) were also plated in serial dilutions up to 10-11 onto anaerobic TSA plates with 
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respective antibiotics added and incubated in a Gas Pac jar at 37º for 24-36 hrs to determine the 
number of viable donor and recipient cells available for conjugation.  
 
Transfer frequencies were calculated by counting the number of viable transconjugants 
growing on the selective TSA plates and expressed as the number of transconjugants per 
recipient cell or per donor cell (range of transfer frequency was calculated from minimum 
number of transconjugants per donor or per recipient cell to maximum number obtained from 
multiple conjugation experiments).  
 
GUS (β-glucuronidase) enzyme assay 
Overnight cultures (1.5 ml) were collected by microcentrifugation (Sorvall biofuge fresco 
Heraeus # 3325B) at 10000 x g, 4ºC, 5 -10 mins. Cell pellets were washed twice and 
resuspended in 1ml Buffer A (50 mM Na2HPO4 at pH 7.0 and 1 mM EDTA; autoclaved). 
Freshly prepared substrate pNPG (p-nitrophenyl β-D glucuronide) (Sigma Chemical Co., 
St.Louis, MO) was added at a final concentration of 8 mM to 100 µl of enzyme. The total 
volume of the reaction mixture of 200 µl was incubated at 37ºC for 60 mins. Reactions were 
stopped by the addition of 100 µl of Na2CO3. Samples were pelleted by centrifugation (10000 x 
g, 4ºC, 10 mins) and the supernatant diluted with 300 µl sterile water and absorbance at 410 nm 
was determined. Extinction coefficient for pNPG substrate (Emmolar at 410 nm) was taken to be 
18.4 (17). 
 
For enzyme assays in cell lysates, the pelleted cells were resuspended in 1ml Buffer A and 
subjected to bead beating using 0.1 mm glass beads (1 g suspended in 1 ml sterile npH20) in a 
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Mini Bead Beater (Biospec Products, Minebea Co. Ltd., Thailand). Cell suspension (500 µl) was 
added to ~200 µl bead solution in a screw cap non-skirted sterile microfuge tube and beaten at 
5000 rpm for 180 seconds, at intervals of 20 seconds each, with cooling on ice in between the 
bead beating steps to prevent excessive heating. The lysed cells were centrifuged for 4 minutes at 
10000 x g and 4ºC to pellet cell debris. The supernatant was aspirated and used for GUS enzyme 
analysis as described above. 
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FIG. 4. Physical and genetic map of pECU-001. pECU-001 is a derivative of pJIR750 originally 
isolated from Clostridium perfringens (3), modified by ligation of the Birmingham IncP oriT into 
the SpeI site. Genetic symbols represent lacZ’, β-galactosidase α-peptide gene from pUC18; 
oriCP and oriEC, origins of replication from pIP404 and pUC18 respectively; rep, replication 
gene from pIP404; catP, chloramphenicol resistance gene from C. perfringens; oriT, origin of 
transfer from the Birmingham IncP plasmid RP4. Arrows depict direction of transcription. 
(James Coleman, personal communication).  
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FIG. 5. Physical and genetic map of pWKU-001 (Doerner, unpublished data, 1999).  pWKU-001 
is a derivative of pECU-001 (3) (James Coleman, personal communication). Genetic symbols 
represent lacZ’, β-galactosidase α-peptide gene from pUC18; oriCP and oriEC, origins of 
replication from pIP404 and pUC18 respectively; rep, replication gene from pIP404; catP, 
chloramphenicol resistance gene from C. perfringens; oriT, origin of transfer from the 
Birmingham IncP plasmid RP4; baiP: 195-bp bile acid inducible promoter construct from 
Clostridium scindens VPI 12708; GUS: 1.9-kb reporter gene that encodes E. coli b-
glucuronidase (uidA) (15). Arrows depict direction of transcription. 
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FIG. 6. Physical and genetic map of pWKU-002.  pWKU-002 is a derivative of pECU-001 (3) 
(James Coleman, personal communication). Genetic symbols represent lacZ’, β-galactosidase α-
peptide gene from pUC18; oriCP and oriEC, origins of replication from pIP404 and pUC18 
respectively; rep, replication gene from pIP404; catP, chloramphenicol resistance gene from C. 
perfringens;  oriT, origin of transfer from the Birmingham IncP plasmid RP4; baiP: 195-bp bile 
acid inducible promoter construct from Clostridium scindens VPI 12708; GUS: 1.9-kb reporter 
gene that encodes E. coli b-glucuronidase (uidA) (15); Tr, 90-bp bile acid 7α-hydroxysteroid 
dehydrogenase transcriptional terminator. Arrows depict direction of transcription. (Doerner, K. 
C., unpublished data, 1999). 
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CHAPTER III 
RESULTS 
 
A. Aerobic mating of donor E. coli S17-1 harboring pECU-001 with recipient E. coli 
EM24NR 
Initial conjugation experiments were conducted with the donor E. coli S17-1 containing the 
plasmid pECU-001 (conferring chloramphenicol resistance) and the rifampin resistant recipient 
E. coli EM24NR. The donor and recipient cells were grown to an OD 600nm of 0.3-0.5 and mixed 
in sterile 2 ml microfuge tubes. Cultures were mixed in the ratios of 1:8 and 8:1(v/v) to a total 
volume of 1125 µl and incubated at 37ºC. At zero time, thirty mins, sixty mins and overnight 
incubation at 37ºC, 100 µl of the mating mixtures were plated in serial dilutions onto LB plates 
containing the antibiotics rifampin (10 µg/ml) and chloramphenicol (10 µg/ml).  
Chloramphenicol- and rifampin-resistant colonies were observed, suggesting successful 
conjugation (Table 1). Negative controls with 250 µl of donor or recipient cultures were 
incubated in sterile 2 ml microfuge tubes at 37ºC, and were plated onto LB plates containing 
both rifampin (10 µg/ml) and chloramphenicol (10 µg/ml). A few colonies were observed after 
overnight incubation.  
 
     The experiment was repeated with an increased concentration of chloramphenicol (20 µg/ml) 
(Table 2). Successful conjugation was observed at thirty, sixty mins and overnight conjugation, 
and both positive and negative controls were maintained. Both the donor and the recipient grew 
in the presence of the appropriate antibiotics (positive control) and no growth was observed 
when the donor or recipient was grown in the presence of both antibiotics (negative control). 
 25
Putative transconjugants were confirmed by restreaking onto LB plates containing both rifampin 
(20 µg/ml) and chloramphenicol (10 µg/ml). Representative colonies from thirty mins, sixty 
mins and overnight conjugation were picked and inoculated into LB broth with both antibiotics 
added, grown overnight and subjected to plasmid preparation and gel electrophoretic analysis. 
The data indicate the donor contains pECU-001 (lanes 2, 3), the recipient does not contain 
plasmid DNA (lanes 5, 6) and pECU-001 is present in all other transconjugants (Fig. 7).  
 
B. Anaerobic mating of donor E. coli S17-1 harboring pECU-001 with the recipient E. coli 
EM24NR 
The donor and recipient cultures were allowed to grow aerobically to an optical density of 
0.3-0.5 at 600 nm, pelleted, washed in anaerobic diluent, mixed in ratios of 1:2, 2:1, 4:1 and 1:4 
(v/v) of donor to recipient cultures. Donor and recipient cells were mixed on the surface of 
tryptic soy agar slants, incubated for zero mins, sixty mins and overnight at 37ºC and plated (100 
µl) in serial dilutions onto anaerobic selective antibiotic plates maintained in Gas Pac Jars and 
observed for growth after 24 hrs incubation at 37ºC. Putative transconjugants were obtained after 
sixty mins and overnight incubation (Table 3). Colonies were observed after zero mins of 
conjugation. Moderate to confluent growth was observed on plates with intact mating mixtures 
plated after sixty mins and overnight conjugation times. 
 
C. Anaerobic mating of donor E. coli S17-1 harboring pECU-001 with the recipient 
Clostridium scindens VPI 12708Rif 
E. coli EM24NR served as the mating control in these experiments. Donor and recipient cells 
were mixed in the ratios of 1:4 and 4:1 (v/v) on the surface of tryptic soy agar (TSA) slants, 
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incubated overnight at 37ºC and plated (100 µl) in serial dilutions (to10-3) onto TSA plates 
containing the selective antibiotics rifampin (20 µg/ml) and chloramphenicol (20 µg/ml).  
Chloramphenicol- and rifampin-resistant putative transconjugant colonies were observed (Table 
4). Positive controls of donor or recipient plated onto appropriate antibiotic plates grew well. No 
growth was observed when donor or recipient were plated individually in the presence of both 
antibiotics (negative control) after overnight incubation at 37ºC, however a few rifampin tolerant 
colonies were observed when E. coli S17-1 was plated onto TSA plates with 20 µg/ml rifampin 
at time zero. The majority of these colonies did not show growth upon restreaking. Mating 
control was maintained by mixing donor E. coli S17-1 with E. coli EM24NR at 4:1 and 2:1 (v/v) 
ratios at the surface of TSA slants, incubating overnight at 37ºC and plating 100 µl onto TSA 
plates with both antibiotics added.  
 
Rifampin concentration was determined by antibiotic sensitivity experiments. E. coli S17-1 
grew anaerobically in TSA plates containing rifampin up to a concentration of 18 µg/ml, and 
Clostridium scindens VPI 12708Rif grew in anaerobically maintained TSA plates with rifampin 
up to 25 µg/ml (maximum tested) (Fig. 8). For counter-selection against E. coli S17-1, rifampin 
was used at a concentration of 20 µg/ml in the conjugation experiments.  
 
Significant cell mortality was observed when Clostridium scindens VPI 12708Rif was 
subjected to three washes with anaerobic diluent (data not shown). Cell survival greatly 
improved when Clostridium scindens VPI 12708Rif was grown overnight in the absence of 
rifampin and pelleted only once and resuspended in sterile anaerobic BHI broth prior to mating. 
In each of the experiments conducted, positive controls were maintained, and it was confirmed 
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that the cultures were viable before and after mating. Discrete colonies were observed when E. 
coli S17-1 was grown at zero time in the presence of the antibiotic rifampin, but inhibition of 
growth was observed when the overnight culture was grown in the presence of chloramphenicol 
and rifampin.   
 
Putative transconjugants increased in frequency when the donor was harvested in the mid-
logarithmic phase of growth, i.e. at an optical density of 0.5-0.7. More putative transconjugants 
were also observed with the donor: recipient ratio of 4:1, i.e., with a greater number of donor 
cells (data not shown).  
 
This conjugation experiment was conducted no less than nine times, with transconjugants 
observed in seven of the experiments. The two failed experiments had increased mortality of 
Clostridium scindens VPI 12708Rif, likely due to inadequate maintenance of anaerobiosis. 
Transfer frequencies of 0.2 - 3.0 x 10-4 per donor cell and 0.04 – 0.5 x 10-4 per recipient cell were 
obtained by this procedure (Table 5). 
 
Putative transconjugants were restreaked no less than two times onto selective anaerobic 
media and then transferred to 10 ml anaerobic brain heart infusion (BHI) broth to observe growth 
characteristics. The presence of pECU-001 in the putative transconjugant was confirmed by gel 
electrophoretic analysis of the plasmid preparations. Gram staining also was performed on the 
cultures. 
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For culture characteristic analysis, donor, recipient and putative transconjugants were grown 
in anaerobic BHI broth (Fig. 10a 1-3). Donor E. coli S17-1 harboring pECU-001 exhibited turbid 
growth at the top of the broth with little gas production at 12-18 hours of incubation at 37ºC, and 
settled at the bottom of the tube after approximately 24-36 hours. Similar growth rates were 
observed when E. coli S17-1 was grown in LB broth with chloramphenicol (data not shown). 
Recipient Clostridium scindens VPI 12708Rif readily gassed and grew thickly throughout the 
tube in a stringy fashion at 12-24 hours. The putative transconjugants harboring pECU-001 
resembled the recipient in terms of apparent amount of gas produced, but differed in the respect 
that the transconjugants grew nearer to the bottom of the tube. The putative transconjugants also 
exhibited a slower growth than the recipient, with similar turbidity and viscous growth achieved 
at 36-48 hours after inoculation, and similar stringy sedimentation was found after 48-72 hours.  
 
The donor, recipient and putative transconjugant cultures were subjected to gram staining and 
were observed for microscopic morphology. E. coli S17-1 stained Gram negative and consisted 
of short pink rods that occurred singly and sometimes formed short chains. Clostridium scindens 
VPI 12708Rif stained Gram-positive or Gram-variable depending on the age of the culture, and 
consisted of long slender rods that grouped together. The putative transconjugants harboring 
pECU-001 resembled the recipient, with long slender rods that varied in length (Fig. 10b A-C).  
 
Plasmids also were prepared from donor, recipient, and putative transconjugant cultures and 
subjected to 1% agarose gel electrophoretic analysis after digestion with restriction enzymes. 
Ethidium bromide staining demonstrated the presence of pECU-001 in the donor and putative 
transconjugant samples, and absence in the recipient samples (Fig. 9). pECU-001 was 
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maintained in the transconjugant and had similar properties as in the donor. This suggests 
conjugal transfer of pECU-001 into Clostridium scindens VPI 12708.  
 
The rifampin sensitivity experiment was repeated to demonstrate that rifampin-resistant 
mutants spontaneously arise, and rifampin tolerant growth was observed at all concentrations of 
rifampin tested (up to a maximum of 30 µg/ml), under both aerobic and anaerobic conditions. 
However, contrary to expectations, fewer rifampin-tolerant E. coli S17-1 mutants were observed 
under anaerobic conditions when compared to aerobic conditions (Fig. 12). 
 
D. Anaerobic mating of donor E. coli S17-1 harboring pWKU-001 with the recipient 
Clostridium scindens VPI 12708Rif 
The ability of E. coli S17-1 to conjugally transfer pWKU-001 to a recipient was confirmed 
by conducting a conjugation experiment with the recipient E. coli EM24NR (data not shown). In 
experiments with Clostridium scindens VPI 12708Rif as the recipient, rifampin was initially used 
for selection against E. coli S17-1, but as E. coli became tolerant to rifampin (data not shown), 
erythromycin was substituted. Concurrently, it was determined that wild-type Clostridium 
scindens VPI 12708 was resistant to erythromycin (Tirumala, V. and Doerner, K.C, unpublished 
data, 2003), and sensitivity experiments were conducted to determine the tolerance of E. coli 
S17-1 (harboring pECU-001) to the antibiotic in both aerobic and anaerobic conditions. E. coli 
S17-1 was tolerant to the antibiotic at concentrations of 5 µg/ml in aerobic conditions and up to 
30 µg/ml under anaerobic conditions (Fig. 11). Repetition of the erythromycin sensitivities 
demonstrated erythromycin tolerant E. coli S17-1 (with pECU-001) colonies even up to 
concentrations of 30 µg/ml under both aerobic and anaerobic conditions (data not shown). A 
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conjugation experiment attempting transfer of pWKU-001 between donor E. coli S17-1 and 
recipient Clostridium scindens VPI 12708 conducted with erythromycin (50 µg/ml) for selection 
yielded erythromycin-tolerant E. coli S17-1. Erythromycin sensitivity (under anaerobic 
conditions) of E. coli S17-1 harboring pWKU-001 was then conducted and sensitivity to 
erythromycin was found at a concentration of 100 µg/ml in broth (Table 7). Hence, 100 µg/ml of 
erythromycin was used as a selection marker in further conjugation experiments. 
 
The donor and recipient cultures were mixed in the ratios of 1:4 and 4:1 (v/v) on the surface 
of TSA slants and 150 µl of the harvested cells were plated on TSA plates containing both the 
selective antibiotics, and incubated for 36-48 hours. Chloramphenicol resistant growth was 
observed and this was streaked for isolation. However, isolated colonies could not be obtained by 
this method, and no growth was seen upon streaking for more than once on selective TSA plates. 
The putative transconjugants grew readily in broth, and the presence of pWKU-001 was 
confirmed in the initial cultures by gel electrophoresis (Fig.13A). Upon serial transfer of the 
cultures in selective broth, the plasmid was no longer observed (Fig. 13B). This result was 
observed (no less than five times) with several plasmid preparation analyses. The putative 
transconjugants also exhibited a slower growth than the recipient, with approximately similar 
turbid and viscous growth achieved at 48-60 hours after inoculation. However, after multiple 
serial transfers of the putative transconjugants with the plasmid pWKU-001 in selective broth, 
the growth morphology greatly resembled that of the recipient Clostridium scindens VPI 12708, 
even in terms of time taken to attain turbidity. The recipient and the putative transconjugants 
were obligately anaerobic and did not grow in aerobic media. Gram staining of the putative 
transconjugants demonstrated Gram-variable slender rods that did not differ significantly from 
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the recipient Clostridium scindens VPI 12708. These conjugation experiments were conducted 
no less than five times, and isolated colonies could not be obtained in any of the matings. 
Transfer frequencies could not be calculated, as isolated countable colonies could not be 
obtained. 
 
E. Anaerobic mating of donor E. coli S17-1 harboring pWKU-002 with the recipient 
Clostridium scindens VPI 12708 
Conjugation experiments were conducted to attempt transfer of the plasmid pWKU-002. 
Chloramphenicol concentration and erythromycin concentrations were each at 200 µg/ml. The 
experiments were conducted twice, and no growth of putative transconjugants was observed on 
the selective plates. However, positive and negative controls were adequately maintained (data 
not shown).  
 
β-glucuronidase (GUS) enzyme assays and growth curve experiments 
GUS enzyme assays were conducted using Clostridium scindens VPI 12708 to determine if 
there was any intrinsic activity. As previously observed (25), no β-glucuronidase enzyme activity 
was detected. High levels of GUS activity were observed in E. coli S17-1, as expected.  
 
Conjugal transfer of pWKU-001 between E. coli S17-1 and Clostridium scindens VPI 12708 
was successful (Table 6), however, the putative transconjugants grew poorly in anaerobic TSA 
plates but grew abundantly in BHI broth. It was hypothesized that the putative transconjugants 
were more oxygen-sensitive than Clostridium scindens VPI 12708 and hence did not grow well 
in plates; and that the uidA gene product was somehow responsible for the oxygen-sensitivity, if 
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any. In order to test for the possibility of reporter gene toxicity, growth curve experiments were 
conducted by measuring the optical density at 600 nm hourly on cholic acid (0.1 mM) induced 
and uninduced cultures incubated at 37ºC to determine if the cholic acid induced cultures 
behaved differently when compared to uninduced cultures. No significant difference between the 
two cultures was observed (Fig. 14). A GUS enzyme assay was then used to confirm the 
presence of pWKU-001 in the putative transconjugants. However, initial enzyme assays 
repeatedly failed to detect any measurable β-glucuronidase activity in the putative 
transconjugants, and no significant difference in GUS activity was observed between the cholic 
acid induced and uninduced samples. No detectable enzyme activity was observed in cell lysates. 
The growth curve experiments and enzyme assays conducted before and after induction were 
repeated with four of the isolates (mixed) of the putative transconjugants and with Clostridium 
scindens VPI 12708 (Fig. 15). No demonstrable increase in β-glucuronidase levels was observed 
after induction with cholic acid.  
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TABLE 1.  Aerobic mating of donor E. coli S17-1 harboring pECU-001 with recipient E. coli EM24NR 
using 10 µg/ml chloramphenicol for selectiona 
Ratiob E. coli S17-1 (µl) 
E. coli 
Em24NR 
(µl) 
Timee 
(in minutes) 
Selection 
antibioticc Dilution Results
d 
250 0 0 R+C 1 NG Negative 
control 250 0 0 R+C 1/10 NG 
0 250 0 R+C 1 NG Negative 
control 0 250 0 R+C 1/10 NG 
125 1000 30 R+C 1 ++ 
125 1000 30 R+C 1/10 + 
125 1000 30 R+C 1/100 + 1:8 
125 1000 30 R+C 1/1000 NG 
1000 125 30 R+C 1 ++ 
1000 125 30 R+C 1/10 + 
1000 125 30 R+C 1/100 NG 8:1 
1000 125 30 R+C 1/1000 NG 
125 1000 60 R+C 1 ++ 
125 1000 60 R+C 1/10 + 
125 1000 60 R+C 1/100 + 1:8 
125 1000 60 R+C 1/1000 NG 
1000 125 60 R+C 1 ++ 
1000 125 60 R+C 1/10 + 
1000 125 60 R+C 1/100 NG 8:1 
1000 125 60 R+C 1/1000 NG 
125 1000 O/N+ R+C 1 +++ 
125 1000 O/N+ R+C 1/10 +++ 
125 1000 O/N+ R+C 1/100 ++ 1:8 
125 1000 O/N+ R+C 1/1000 + 
1000 125 O/N+ R+C 1 +++ 
1000 125 O/N+ R+C 1/10 ++ 
1000 125 O/N+ R+C 1/100 + 8:1 
1000 125 O/N+ R+C 1/1000 NG 
250 0 O/N+ R+C 1 + Negative 
control 250 0 O/N+ R+C 1/10 NG 
0 250 O/N+ R+C 1 + Negative 
control 0 250 O/N+ R+C 1/10 + 
250 0 0 C 1 +++ Positive 
control 250 0 0 C 1/10 ++ 
0 250 0 R 1 +++ Positive 
control 0 250 0 R 1/10 ++ 
250 0 O/N+ C 1 +++ Positive 
control 250 0 O/N+ C 1/10 +++ 
0 250 O/N+ R 1 ++ Positive 
control 0 250 O/N+ R 1/10 ++ 
 
a
 The cultures were allowed to grow aerobically to an optical density of 0.3-0.5 at 600 nm, mixed in 
specific v/v ratios in microfuge tubes, incubated for 0, 30, 60 minutes and overnight at 37ºC in a water 
bath and plated (100 µl) onto selective antibiotic plates in serial dilutions and observed for growth after 
24 hrs incubation at 37ºC. 
b
 Relative volume to volume ratios of donor: recipient. 100 µl was plated. 
c
 Antibiotics used for selection on LB agar plates. R, 10 µg/ml rifampin; and C, 10 µg/ml 
chloramphenicol. 
d
 Results were read after 24 hours of incubation of plates. NG, no growth; +++, lawn growth; ++, 
moderate growth with some discrete colonies; +, minimal growth  
e
 All cultures were incubated at 37ºC in a water bath. O/N represents cultures incubated overnight at 37ºC. 
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TABLE 2. Aerobic mating of donor E. coli S17-1 harboring pECU-001 with recipient E. coli EM24NR 
using 20 µg/ml chloramphenicol for selectiona 
 
Ratiob E. coli S17-1 (µl) 
E. coli 
Em24NR (µl) 
Timee 
(in minutes) 
Selection 
antibioticc Dilution Results
d 
100 0 0 R+C 1 NG Negative 
control 0 100 0 R+C 1 NG 
250 0 0 C 1 +++ 
250 0 0 C 1/10 +++ Positive 
control 250 0 0 C 1/100 +++ 
0 250 0 R 1 +++ 
0 250 0 R 1/10 +++ Positive 
control 0 250 0 R 1/100 +++ 
125 1000 30 R+C 1 ++ 
125 1000 30 R+C 1/10 + 
125 1000 30 R+C 1/100 + 1:8 
125 1000 30 R+C 1/1000 + 
1000 125 30 R+C 1 ++ 
1000 125 30 R+C 1/10 + 
1000 125 30 R+C 1/100 + 8:1 
1000 125 30 R+C 1/1000 + 
125 1000 60 R+C 1 ++ 
125 1000 60 R+C 1/10 ++ 
125 1000 60 R+C 1/100 + 1:8 
125 1000 60 R+C 1/1000 + 
1000 125 60 R+C 1 ++ 
1000 125 60 R+C 1/10 ++ 
1000 125 60 R+C 1/100 + 8:1 
1000 125 60 R+C 1/1000 + 
125 1000 O/N R+C 1 +++ 
125 1000 O/N R+C 1/10 +++ 
125 1000 O/N R+C 1/100 ++ 1:8 
125 1000 O/N R+C 1/1000 + 
1000 125 O/N R+C 1 +++ 
1000 125 O/N R+C 1/10 ++ 
1000 125 O/N R+C 1/100 ++ 8:1 
1000 125 O/N R+C 1/1000 + 
250 0 O/N R+C 1 NG 
250 0 O/N R+C 1/10 NG 
250 0 O/N R+C 1/100 NG 
Negative 
control 
250 0 O/N R+C 1/1000 NG 
0 250 O/N R+C 1 NG 
0 250 O/N R+C 1/10 NG 
0 250 O/N R+C 1/100 NG 
Negative 
control 
0 250 O/N R+C 1/1000 NG 
a
 The cultures were allowed to grow aerobically to an optical density of 0.3-0.5 at 600 nm, mixed in 
specific v/v ratios in microfuge tubes, incubated for 30, 60 minutes and overnight at 37ºC in a water 
bath and plated (100 µl) onto selective antibiotic plates in serial dilutions and observed for growth after 
24 hrs incubation at 37ºC. 
b
 Relative volume to volume ratios of donor: recipient. 100 µl was plated. 
c
 Antibiotics used for selection on LB agar plates. R, 10 µg/ml rifampin; and C, 20 µg/ml 
chloramphenicol. 
d 
 Results were read after 24 hours of incubation of plates. NG, no growth; +++, lawn growth; ++, 
moderate growth with some discrete colonies; +, minimal growth.  
e
 All cultures were incubated at 37ºC in a water bath. O/N represents cultures incubated overnight at 37ºC. 
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TABLE 3. Anaerobic mating of donor E. coli S17-1 harboring pECU-001 with recipient E. coli 
EM24NRa 
 
Ratiob E. coli S17-1 (µl) 
E. coli 
Em24NR 
(µl) 
Timee 
(in 
minutes) 
Selection 
antibioticc Results
d 
100 0 0 C +++ Positive 
control 0 100 0 R +++ 
1:2 500 1000 0 R+C + 
1:4 250 1000 0 R+C + 
2:1 1000 500 0 R+C + 
4:1 1000 250 0 R+C + 
1:2 500 1000 60 R+C ++ 
1:4 250 1000 60 R+C ++ 
2:1 1000 500 60 R+C ++ 
4:1 1000 250 60 R+C ++ 
1:2 500 1000 O/N R+C +++ 
1:4 250 1000 O/N R+C +++ 
2:1 1000 500 O/N R+C ++ 
4:1 1000 250 O/N R+C ++ 
1000 0 O/N R+C + Negative 
control 0 1000 O/N R+C NG 
1000 0 O/N C +++ Positive 
control 0 1000 O/N R +++ 
 
a The cultures were allowed to grow aerobically upto an optical density of 0.3-0.5 at 600 nm, 
pelleted, washed in anaerobic diluent, mixed in specific v/v ratios on tryptic soy agar slants, 
incubated for 0, 60 minutes and overnight at 37ºC and plated (100 µl) onto anaerobic selective 
antibiotic plates in serial dilutions and observed for growth after 24 hrs incubation at 37ºC. The 
mating was performed using a benchtop method. 
b Relative volume to volume ratios of donor: recipient. 100 µl was plated. 
c
 Antibiotics used for selection on LB agar plates. R, 10 µg/ml rifampin; and C, 20 µg/ml 
chloramphenicol. 
d
 Results were read after 24 hours of incubation of plates in an anaerobic Gas Pac jar. NG, no 
growth; +++, lawn growth; ++, moderate growth with some discrete colonies; +, minimal 
growth with few discrete colonies. 
e
 All cultures were incubated at 37ºC. O/N represents cultures incubated overnight at 37ºC. 
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TABLE 4. Anaerobic mating of donor E. coli S17-1 harboring pECU-001 with recipient C.  scindens VPI 
12708Rif, and with recipient E. coli EM24NR as a mating control.a 
 
Ratiob 
E. coli 
S17-1 
(µl) 
C. scindens 
VPI 
12708Rif 
(µl) 
E. coli 
Em24NR 
(µl) 
Timee 
(in 
minutes) 
Selection 
antibioticc Dilution
 Resultsd 
100 0 0 0 C 1 +++ 
0 0 100 0 R 1 ++ Positive 
control 0 100 0 0 R 1 +++ 
100 0 0 0 R 1 + Negative 
control 100 0 0 0 R 1/100 + 
0 0 100 0 C 1 NG Negative 
control 0 0 100 0 C 1/100 NG 
0 100 0 0 C 1 NG Negative 
control 0 100 0 0 C 1/100 NG 
1000 0 0 O/N C 1 +++ 
0 0 1000 O/N R 1 +++ Positive 
control 0 1000 0 O/N R 1 +++ 
1000 0 250 O/N R+C 1/100 ++ Mating 
control 1000 0 500 O/N R+C 1/100 ++ 
1000 0 0 O/N R+C 1 NG 
0 0 1000 O/N R+C 1 NG Negative 
control 0 1000 0 O/N R+C 1 NG 
1000 250 0 O/N R+C 1 TNTC 
1000 250 0 O/N R+C 1/10 TNTC 
1000 250 0 O/N R+C 1/100 NG 4:1 
1000 250 0 O/N R+C 1/1000 3 
250 1000 0 O/N R+C 1 TNTC 
250 1000 0 O/N R+C 1/10 32 
250 1000 0 O/N R+C 1/100 41 1:4 
250 1000 0 O/N R+C 1/1000 2 
 
a
 The E. coli cultures were grown aerobically to an optical density of 0.5- 0.7 at 600 nm and C. scindens 
VPI 12708Rif was grown anaerobically in brain heart infusion broth overnight. The cultures were 
pelleted, washed in anaerobic diluent, mixed in specific v/v ratios on rich tryptic soy agar slants, 
incubated overnight at 37ºC and plated (100 µl) onto anaerobic selective antibiotic plates in serial 
dilutions and observed for growth after 36 hrs incubation at 37ºC. The mating was performed using a 
benchtop method. 
b
 Relative volume to volume ratios of donor: recipient. 100 µl was plated. 
c
 Antibiotics used for selection on LB agar plates. R, 20 µg/ml rifampin; and C, 20 µg/ml 
chloramphenicol. 
d
 Results were read after 36 hours of incubation of plates in an anaerobic Gas Pac jar. NG, no growth; 
+++, lawn growth; ++, moderate growth with some discrete colonies; +, minimal growth with very few 
discrete colonies; TNTC, too numerous to count colonies; and the values represent the number of 
colonies observed. 
e
 All cultures were incubated at 37ºC. O/N represents cultures incubated overnight at 37ºC. 
Data are representative of the results obtained from no less than ten conjugation experiments. Eight of the 
ten experiments were successful and yielded putative transconjugants.  
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TABLE 5:  Frequencies of transfer of pECU-001 to recipient Clostridium scindens VPI 12708Rif 
from donor E. coli S17-1. 
 
 
 Transfer frequencya (10-4) 
Per donor 0.2 – 3.0 
Per recipient 0.04 – 0.5 
 
 
 
a
 Data are values calculated from two replicate experiments with mating time of 36-48 hrs. 
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TABLE 6. Anaerobic mating of donor E. coli S17-1 harboring pWKU-001 with    recipient C.  
scindens VPI 12708.a 
 
Ratiob 
E. coli 
S17-1 
(µl) 
C. scindens 
VPI 12708 
(µl) 
Timee 
(in 
minutes) 
Selection 
antibioticc Dilution
 Resultsd 
150 0 0 C 1 TNTC Positive 
control 0 150 0 E 1 TNTC 
150 0 0 E 1/100 NG Negative 
control 0 150 0 C 1/100 NG 
1000 0 O/N C 1 TNTC Positive 
control 0 1000 O/N E 1 TNTC 
1000 250 O/N E+C 1 TNTC 
1000 250 O/N E+C 1/10 TNTC 
1000 250 O/N E+C 1/100 NG 4:1 
1000 250 O/N E+C 1/1000 12 
250 1000 O/N E+C 1 TNTC 
250 1000 O/N E+C 1/10 TNTC 
250 1000 O/N E+C 1/100 ~500 1:4 
250 1000 O/N E+C 1/1000 ~60 
 
a E. coli S17-1 was grown aerobically to an optical density of 0.5- 0.7 at 600 nm and C. scindens 
VPI 12708 was grown anaerobically in brain heart infusion broth overnight. The cultures were 
pelleted, washed in anaerobic diluent, mixed in specific v/v ratios on tryptic soy agar slants, 
incubated overnight at 37ºC, removed with anaerobic diluent and plated (150 µl) onto 
anaerobic selective antibiotic plates in serial dilutions and observed for growth after 48-60 hrs 
incubation at 37ºC. 150 µl was plated. Data are representative of the results obtained from no 
less than three conjugation experiments. 
b
 Volume to volume ratios of donor: recipient.  
c
 Antibiotics used for selection on LB agar plates. E, 100 µg/ml erythromycin; and C, 20 µg/ml 
chloramphenicol. 
d
 Results were read after 48-60 hours of incubation of plates in an anaerobic Gas Pac jar. NG, no 
growth; TNTC, too numerous to count colonies; and the values represent the number of 
colonies observed. The values indicate approximate number of colonies obtained (the colonies 
were too small for accurate counts) 
e
 All cultures were incubated at 37ºC. O/N represents cultures incubated overnight at 37ºC. 
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FIG. 7. Gel electrophoretic analysis of the plasmid preparation of donor E. coli S17-1 with 
pECU-001, recipient E. coli EM24NR and putative transconjugants following various mating 
times. Lanes 2, 3: donor E. coli S17-1; lanes 5, 6: recipient E. coli EM24NR; lanes 8,9: putative 
transconjugant 30 mins; lanes 11,12: putative transconjugant 60 minutes; lanes 15,16: putative 
transconjugant overnight conjugation; lanes 1,13: NEB molecular weight standard. Lanes 2, 5, 8, 
11, 15: uncut samples, while lanes 3, 6, 9, 12, 16: EcoRI digests.  
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FIG. 8.  Determination of rifampin resistance in E. coli S17-1 harboring pECU-001 and 
Clostridium scindens VPI 12708Rif. 100 µl of overnight culture was lawn-streaked onto anaerobic 
tryptic soy agar plates with rifampin at varying concentrations and incubated for 48 hours at 
37ºC in Gas Pac Jars and observed for growth. The dark blocks represent Clostridium scindens 
VPI 12708Rif and the light blocks represent E. coli S17-1. Too numerous to count colonies have 
been represented by the maximum of 1000 CFUs. 
Data are representative of two separate experiments. 
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FIG. 9. Gel electrophoresis of the plasmid preparation from donor E. coli S17-1, recipient 
Clostridium scindens VPI 12708Rif and putative transconjugant on a 1% agarose gel, 
demonstrating the presence of pECU-001. Lane 1: NEB molecular size standard; lanes 3,4,5: 
E.coli S17-1, lanes 7,8,9: Clostridium scindens VPI 12708Rif, lanes 11, 12, 13: putative 
transconjugant. Lanes 3,7,11: undigested; lanes 4,8,12: digested with EcoRI; lanes 5,9,13: 
digested with BamHI.  
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FIG. 10a. Broth characteristics of donor, recipient, and putative transconjugant. The cultures 
were inoculated (1/10) into anaerobic brain heart infusion broth with 1 day old cultures, 
incubated at 37ºC for 24-36 hours and observed for gas production and turbidity.  (1) 
Clostridium scindens VPI 12708Rif. (2) E. coli S17-1 harboring pECU-001 and (3) putative 
transconjugant with pECU-001.  
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FIG. 10b. Gram stain and morphology of the donor, recipient and putative transconjugant 
containing pECU-001. Microphotographs demonstrating (A) Gram positive  (recipient) 
Clostridium scindens VPI 12708Rif. (B) Gram negative (donor) E. coli S17-1 (C) Gram positive 
putative transconjugant  
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FIG. 11. Determination of antibiotic erythromycin sensitivity in E. coli S17-1 with pECU-001 
under aerobic and anaerobic conditions. 100 µl of an overnight culture of E. coli S17-1 was 
lawn-streaked onto tryptic soy agar plates with erythromycin at varying concentrations, and the 
plates were incubated aerobically and duplicates were incubated under anaerobic conditions in 
Gas Pac jars at 37ºC for 48 hours and observed for the presence of erythromycin-tolerant colony 
forming units (CFUs). Too numerous to count colonies are represented by the maximum of 1000 
CFUs in the figure. The dark blocks represent anaerobically incubated plates and the light blocks 
represent aerobically incubated plates. 
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FIG. 12. Determination of altered rifampin sensitivity under aerobic and anaerobic conditions in 
E. coli S17-1 harboring pECU-001. 100 µl of an overnight culture of E. coli S17-1 was lawn-
streaked onto tryptic soy agar plates containing rifampin at varying concentrations, and the plates 
were incubated aerobically and duplicates were incubated under anaerobic conditions in Gas Pac 
jars at 37ºC for 48 hours and observed for the presence of rifampin-tolerant colony forming units 
(CFUs). Too numerous to count colonies are represented by the maximum of 1000 CFUs in the 
figure. The dark blocks represent anaerobically incubated plates and the light blocks represent 
aerobically incubated plates. 
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              A.          B.    
 
 
FIG. 13. Gel electrophoretic analysis of plasmid preparations from donor E. coli S17-1 harboring 
pWKU-001, recipient Clostridium scindens VPI 12708 and putative transconjugant(s) run on 1% 
agarose gel stained with ethidium bromide. (A) Lane 1: NEB molecular weight standard; lane 3: 
undigested and lane 4: EcoRI digest. (B) Lane1: 1kb molecular weight standard; lanes 2,3: E. 
coli S17-1; lanes 4,5: Clostridium scindens VPI 12708; lanes 6-17: different isolates of the 
putative transconjugant. Lanes 2, 4, 6, 8, 10, 12, 14, 16: samples digested with EcoRI, lanes 3,5, 
7, 9, 11, 13, 15, 17: samples digested with SmaI. 
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FIG. 14. Growth curve analysis of the putative transconjugant harboring pWKU-001. 100 ml 
sterile BHI media with selective antibiotics added was inoculated (1/20) with the putative 
transconjugant incubated at 37ºC, OD 600nm measured at hourly intervals and the results were 
graphically represented. Cholic acid (0.1 mM) was added (large arrow) to the bile induced 
culture (∆) and sterile water was added to the uninduced ( ) culture. 
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FIG. 15. Growth curve analysis of C.  scindens VPI 12708 and putative transconjugants 
harboring pWKU-001. 100 ml sterile BHI with selective antibiotics added was inoculated (1/20) 
with the putative transconjugants or C. scindens and incubated at 37ºC, OD 600nm measured at 
hourly intervals and the results were graphically represented. A, B, 5, and D, various cultures of 
putative transconjugants; test, samples induced with 0.1 mM cholic acid; control, uninduced 
samples. Arrow indicates bile acid addition to the induced cultures. 
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TABLE 7. Erythromycin sensitivities of E. coli S17-1 with pWKU-001 and Clostridium scindens 
VPI 12708a. 
 
 
100 µg/ml erythromycin 100 µg/ml erythromycin + 20 µg/ml rifampin Bacterial strain 
Turbidity Gas production Turbidity 
Gas 
production 
E. coli S17-1 with pWKU-
001 No growth Nil No growth Nil 
Clostridium scindens VPI 
12708 +++ + +++ + 
 
a
 Bacterial strains were inoculated (1/10) into 10 ml anaerobic BHI broth and incubated at 37ºC 
for 36 hours and observed for growth and gas production. +++, turbid growth ; +, gas produced. 
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CHAPTER IV 
DISCUSSION 
 
In order to characterize the baiP promoter, a functional method of gene transfer into the 
bacterium is required. We have demonstrated that conjugation by a simple reproducible bench 
top method is an efficient method of transfer of plasmids with RP4 capability. The results 
indicate that E. coli S17-1 can serve as a conjugal donor for plasmid transfer to Clostridium 
scindens VPI 12708. Also, the plasmid pECU-001 could serve as an excellent shuttle vector 
between E. coli S17-1 and Clostridium scindens VPI 12708. 
 
     Most of the problems associated with conjugal transfer between facultatively anaerobic 
Gram-negative E. coli and obligately anaerobic Gram-positive Clostridium scindens VPI 12708 
have been addressed. E. coli S17-1, with the transfer (mobilization) genes of the Birmingham 
IncPα-type plasmid RP4 integrated into the chromosome, was utilized as the conjugal donor (38, 
43). The vector plasmids, pECU-001, pWKU-001 and pWKU-002, are derivatives of the 
Clostridium perfringens shuttle vector pJIR750. pJIR750 has ori sequences for E. coli and 
Clostridium perfringens, and a chloramphenicol acetyl transferase gene that renders the host 
chloramphenicol resistant. pECU-001 has in addition an origin of transfer region from the IncP 
RK231 plasmid, another broad host range vector. A similarly designed system has been 
demonstrated to successfully transfer the vector between E. coli host and Clostridium 
perfringens recipient using an anaerobic chamber (27).  It was hypothesized that this system 
would work in Clostridium scindens VPI 12708, and it was attempted to simplify the process 
without the use of an anaerobic chamber. The potential problem of anaerobiosis was tackled by 
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packing together facultatively anaerobic donor E. coli cells around the anaerobic recipient during 
conjugation, the idea being that any oxygen in the tube would be scavenged by the E. coli, thus 
ensuring an anaerobic environment for Clostridium scindens VPI 12708 (40). Also, the media 
plates were incubated in anaerobic Gas Pac jars with a palladium catalyst to facilitate bench top 
anaerobiosis. 
 
The results indicate that anaerobic incubation with the donor and recipient immobilized on an 
agar surface provides adequate support for mating (Tables 1-4). However, the efficiency of cell 
recovery from the matrix of the agar surface cannot be calculated using this method. It is likely 
that cell recovery is poor, so this procedure is recommended only for qualitative conjugation 
experiments. It is difficult to use this method, by the same argument, to quantify the precise 
number of matings. Transfer frequencies of 0.2 x 10-4 –3.0 x 10-4 per donor cell and 0.04 x 10-4 – 
0.5 x 10-4 per recipient cell were obtained for the conjugal transfer of the vector pECU-001. It 
can be expected that the actual transfer frequency would be higher if all the cells were to be 
recovered.  
 
However, transfer frequencies could not be obtained with matings involving pWKU-001 as 
the shuttle vector. Isolated colonies could not be obtained with this method. As demonstrated by 
gel electrophoresis, the plasmid was successfully transferred to the recipient, however it was not 
stable (Fig. 13A and Fig. 13B). It is possible that the putative transconjugant developed tolerance 
to chloramphenicol and the plasmid was lost. As the putative transconjugant was constantly 
cultured in chloramphenicol, it is possible that a spontaneous chloramphenicol mutant arose. It 
can be hypothesized that as spontaneous chloramphenicol resistance increased in the culture, the 
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requirement for the plasmid decreased. It is possible that as the plasmid was not required for 
survival in the presence of chloramphenicol, it was lost.  
 
Alternatively, the GUS reporter gene could be toxic to the cell. In order to test this 
hypothesis, growth curve analysis was performed on bile acid induced and uninduced putative 
transconjugant cultures. It was hypothesized that if reporter gene toxicity was indeed present 
then a difference in growth rates would be observed between the bile acid induced and 
uninduced samples. However, growth curve experiments demonstrated no difference in cell 
viability in the cholic acid induced and uninduced samples, thus eschewing this hypothesis (Fig. 
8). In addition, no demonstrable increase of GUS activity upon bile acid induction in the putative 
transconjugants was observed. This confounds the results of the growth curve analysis, as it is 
uncertain if the promoter itself was functional. In addition, as noted previously (25), Clostridium 
scindens VPI 12708 did not exhibit any β-glucuronidase enzyme activity (Fig. 9).  
 
Possible explanations for lack of induction by cholic acid in the putative transconjugant 
include: a) the plasmid was absent in the putative transconjugant, possibly due to an increase in 
cell chloramphenicol resistance, b) promoter was inactive or nonfunctional, c) the reporter gene 
was not induced by the promoter, d) the reporter gene was transcribed but not translated, or e) 
the β-glucuronidase protein was misfolded and inactive.  
 
Changes in level of antibiotic sensitivity of E. coli S17-1 were also a problem. It was noted 
that E. coli S17-1 was susceptible to an antibiotic in aerobic conditions but became tolerant to 
the antibiotic at the same concentration when plated under anaerobic conditions.  It is possible 
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that this is related to the oxygen requirements of the protein responsible for antibiotic resistance. 
It is also interesting that E. coli S17-1 harboring pWKU-001 was more tolerant to rifampin than 
E. coli S17-1 harboring the smaller pECU-001. Perhaps antibiotic resistance also is dependent on 
the metabolic requirements of the cell, as the cell harboring a larger plasmid would have 
different metabolic requirements than a cell harboring a smaller plasmid. Since the donor E. coli 
S17-1 quickly became tolerant to rifampin, in experiments involving transfer of pWKU-001 and 
pWKU-002, erythromycin (100 µg/ml) was used for recipient selection. The concentrations of 
both chloramphenicol and erythromycin were increased to 200 µg/ml in the conjugation 
experiments involving pWKU-002. However, whether it is a good idea to increase antibiotic 
concentration to higher levels to circumvent the potential development of antibiotic resistance is 
confounded by the fact that no putative transconjugants were obtained in these experiments.   
 
It is interesting that a commercially available plasmid preparation kit, utilizing the alkaline 
lysis method, extracted plasmids from Clostridium scindens VPI 12708 transconjugants, and 
yielded  ~2-5ng DNA/µl, with a similar high copy number as in the donor E. coli S17-1 as 
demonstrated by the gel electrophoresis photographs. This suggests the cell wall of Clostridium 
scindens VPI 12708 is sensitive to lysozyme and is lysed easily under standard conditions. This 
observation should simplify the genetic analysis of the strain.  
 
The data suggest that the method of conjugation followed in this study could be useful 
because mating can occur on the bench top or in an incubator in anaerobic agar tubes rather than 
mating on membranes, as is traditionally done. Furthermore, these data suggest that the 
Clostridium perfringens plasmid pECU-001 can be successfully used as a vector to introduce 
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genetic constructs in Clostridium scindens VPI 12708. The results indicate that the 
chloramphenicol resistance marker is adequately expressed and the origin of replication (oriCP) 
is functional even in Clostridium scindens VPI 12708.  
 
However, pWKU-001 is not stable in the transconjugant and pWKU-002 could not be 
transported into Clostridium scindens VPI 12708. A better understanding of the confounding 
problems associated with these shuttle vectors is needed. This will be crucial in the successful 
development of a system of genetic transfer into the bacterium Clostridium scindens VPI 12708 
to characterize the bai promoter region. An elucidation of the mechanism of action of the bai 
promoter is required to understand the process of 7α-dehydroxylation that converts primary bile 
acids to secondary bile acids.  
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